Amphastar Pharmaceuticals(AMPH)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

AMPH Amphastar Pharmaceuticals

盘前交易 07-22 06:23:52 EDT

39.61

-0.14

-0.35%

最高40.37	最低39.57	成交量31.42万
今开39.80	昨收39.75	日振幅2.01%
总市值19.37亿	流通市值15.06亿	总股本4,890万
成交额1,254万	换手率0.83%	流通股本3,802万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"AMPH","market":"US","secType":"STK","nameCN":"Amphastar Pharmaceuticals","latestPrice":39.61,"timestamp":1721419200000,"preClose":39.75,"halted":0,"volume":314230,"delay":0,"floatShares":38017854,"shares":48901965,"eps":2.905614,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.14,"latestTime":"07-22 06:23:52 EDT","open":39.8,"high":40.37,"low":39.57,"amount":12542451.17125,"amplitude":0.020126,"askPrice":48.82,"askSize":100,"bidPrice":30.18,"bidSize":100,"shortable":3,"etf":0,"ttmEps":2.905614,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721655000000},"adr":0,"listingDate":1403668800000,"adjPreClose":39.61,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":40,"preClose":39.61,"latestTime":"16:55 EDT","volume":14272,"amount":565369.22,"timestamp":1721422543613},"volumeRatio":0.8961980200372818,"impliedVol":0.2939,"impliedVolPercentile":0.052},"requestUrl":"/m/hq/s/AMPH/wiki","defaultTab":"wiki","newsList":[{"id":"2450390395","title":"Amphastar Pharmaceuticals, Inc.盘中异动 股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450390395","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450390395?lang=zh_cn&edition=full","pubTime":"2024-07-12 03:25","pubTimestamp":1720725949,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日03时25分，Amphastar Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.08%。Amphastar Pharmaceuticals, Inc.股票所在的制药行业中，整体跌幅为0.11%。Amphastar Pharmaceuticals, Inc.公司简介：Amphastar Pharmaceuticals Inc 是一家生物制药公司，专注于开发、制造、营销和销售技术上具有挑战性的仿制和专有注射、吸入和鼻内产品。消息层面，截至03时25分，《美银证券维持Amphastar Pharmaceuticals持有评级》资讯为影响Amphastar Pharmaceuticals, Inc.的重要信息。该信息摘要如下：美银证券分析师Jason Gerberry维持$Amphastar Pharmaceuticals $持有评级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407120325499681c14d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407120325499681c14d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4557","BK4007","AMPH","BK4588"],"gpt_icon":0},{"id":"2448915363","title":"Amphastar Pharmaceuticals, Inc.盘中异动 早盘股价大跌6.23%报37.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448915363","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448915363?lang=zh_cn&edition=full","pubTime":"2024-07-01 21:45","pubTimestamp":1719841503,"startTime":"0","endTime":"0","summary":"北京时间2024年07月01日21时45分，Amphastar Pharmaceuticals, Inc.股票出现异动，股价快速下跌6.23%。Amphastar Pharmaceuticals, Inc.股票所在的制药行业中，整体涨幅为0.68%。消息层面，截至21时45分，《Form 144 | Amphastar Pharmaceuticals高管拟出售3,596股股份，价值约14.46万美元》资讯为影响Amphastar Pharmaceuticals, Inc.的重要信息。该信息摘要如下：根据美国证券交易委员会美东时间6月27日披露的文件，$Amphastar Pharmaceuticals $高管PETERS WILLIAM J拟于6月27日出售3,596股普通股股份，总市值约14.46万美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701214504968186e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701214504968186e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMPH","BK4585","BK4588","BK4557","BK4007"],"gpt_icon":0},{"id":"2437201425","title":"BUZZ-印度鲁邦因担心呼吸系统药物在美国失去市场份额而下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2437201425","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437201425?lang=zh_cn&edition=full","pubTime":"2024-05-23 14:10","pubTimestamp":1716444638,"startTime":"0","endTime":"0","summary":"    5月23日 - ** 印度制药商Lupin  股价下跌7.3%，报1,591.20卢比；创下自2023年2月以来的最大日内跌幅。** 总部位于美国的 Amphastar Pharmaceuticals    周三表示，该公司用于治疗呼吸系统疾病的硫酸沙丁胺醇吸入气雾剂获得了美国食品及药物管理局的批准。** 鲁邦在美国拥有该药 23.4% 的市场份额** Nuvama Institutional Equities 制药公司分析师 Shrikant Akolkar 说：\"市场的反应是，鲁邦的主要产品之一现在的定价很容易引起竞争。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMPH","BK4557","BK4007","BK4585","BUZZ","BK4588"],"gpt_icon":0},{"id":"2437299872","title":"Amphastar Pharmaceuticals, Inc.盘中异动 急速拉升5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2437299872","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437299872?lang=zh_cn&edition=full","pubTime":"2024-05-22 21:56","pubTimestamp":1716386168,"startTime":"0","endTime":"0","summary":"北京时间2024年05月22日21时56分，Amphastar Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.11%。Amphastar Pharmaceuticals, Inc.股票所在的制药行业中，整体跌幅为0.40%。其相关个股中，Sunshine Biopharma Inc C/Wts 、Painreform Ltd.、Amphastar Pharmaceuticals, Inc.涨幅较大，Sunshine Biopharma Inc.、Akanda Corp.、苏轩堂较为活跃，换手率分别为70.49%、27.50%、12.00%，振幅较大的相关个股有Evoke Pharma, Inc.、祁连国际、Im Cannabis Corp.，振幅分别为19.96%、17.03%、15.01%。Amphastar Pharmaceuticals, Inc.公司简介：Amphastar Pharmaceuticals Inc 是一家生物制药公司，专注于开发、制造、营销和销售技术上具有挑战性的仿制和专有注射、吸入和鼻内产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240522215608941e9733&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240522215608941e9733&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4007","AMPH","BK4585","BK4557"],"gpt_icon":0},{"id":"2436094662","title":"Amphastar Pharmaceuticals, Inc.2024财年第一财季实现净利润43.18百万美元，同比增加65.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2436094662","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2436094662?lang=zh_cn&edition=full","pubTime":"2024-05-18 00:19","pubTimestamp":1715962778,"startTime":"0","endTime":"0","summary":"3月31日，Amphastar Pharmaceuticals, Inc.公布财报，公告显示公司2024财年第一财季净利润为43.18百万美元，同比增加65.89%；其中营业收入为1.72亿美元，同比增加22.86%，每股基本收益为0.90美元。从资产负债表来看，Amphastar Pharmaceuticals, Inc.总负债9.02亿美元，其中短期债务4.37百万美元，资产负债比为1.75，流动比率为2.18。机构评级：截至2024年3月31日，当前有5家机构对Amphastar Pharmaceuticals, Inc.目标价做出预测，其中目标均价为62.60美元，其中最低目标价为50.00美元，最高目标价为71.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405180019488b131a06&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405180019488b131a06&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMPH"],"gpt_icon":0},{"id":"2434001835","title":"Amphastar Pharmaceuticals, Inc.盘中异动 早盘急速上涨7.94%报45.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434001835","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434001835?lang=zh_cn&edition=full","pubTime":"2024-05-09 21:30","pubTimestamp":1715261403,"startTime":"0","endTime":"0","summary":"北京时间2024年05月09日21时30分，Amphastar Pharmaceuticals, Inc.股票出现波动，股价急速拉升7.94%。Amphastar Pharmaceuticals, Inc.股票所在的制药行业中，整体跌幅为0.20%。其相关个股中，Amphastar Pharmaceuticals, Inc.、Biofrontera Inc.、硕腾涨幅较大，Sunshine Biopharma Inc.、Sonoma Pharmaceuticals, Inc.、苏轩堂较为活跃，换手率分别为20.94%、1.71%、1.45%，振幅较大的相关个股有硕腾、Cbdmd, Inc.、晖致，振幅分别为0.00%、0.00%、0.00%。Amphastar Pharmaceuticals, Inc.公司简介：Amphastar Pharmaceuticals Inc 是一家生物制药公司，专注于开发、制造、营销和销售技术上具有挑战性的仿制和专有注射、吸入和鼻内产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240509213004861ec174&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240509213004861ec174&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4557","BK4007","AMPH","BK4588"],"gpt_icon":0},{"id":"2433705267","title":"Amphastar Pharmaceuticals Inc    预计每股收益 77 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2433705267","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433705267?lang=zh_cn&edition=full","pubTime":"2024-05-07 10:12","pubTimestamp":1715047943,"startTime":"0","endTime":"0","summary":"   * Amphastar Pharmaceuticals Inc     将于5月8日公布截至2024年3月31日的财报，预计该公司的季度收入将有所增长。* 根据LSEG的数据，6位分析师的平均预期显示，这家总部位于加利福尼亚州Rancho Cucamonga的公司的营收将从去年同期的1.4002亿美元增至1.74713亿美元，增幅为24.8%。* LSEG 分析师对 Amphastar Pharmaceuticals Inc 的平均预期为每股收益 77 美分。* 华尔街对 Amphastar Pharmaceuticals Inc 的 12 个月目标价中位数为 66.00 美元，高于其上次收盘价 42.68 美元。5月7日 - 上一季度业绩。除非另有说明，所有数字均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMPH"],"gpt_icon":0},{"id":"2417200459","title":"美国研究综述-树皮、Fleetcor Technologies、特斯拉","url":"https://stock-news.laohu8.com/highlight/detail?id=2417200459","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2417200459?lang=zh_cn&edition=full","pubTime":"2024-03-05 14:57","pubTimestamp":1709621845,"startTime":"0","endTime":"0","summary":"    路透社3月5日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括 Bark、Fleetcor Technologies 和特斯拉。要闻             * Bark Inc   ：杰富瑞将其评级从 \"持有 \"上调至 \"买入\"；将交易价从1.54美元上调至1.9美元。* Fleetcor Technologies Inc   ：贝尔德将其评级上调至 \"跑赢大盘\"。* 特斯拉  ：加拿大皇家银行将目标价从297美元上调至298美元 以下是路透社周二报道的美国公司研究报告摘要。股票条目按字母顺序排列。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CCCC","PCAR","LU1670628061.USD","LU1861558580.USD","BK4149","GWW","BARK","HGV","PRVA","TSLL","XPOF","UNH","PNTG","APLS","BLUE","LU0011850046.USD","APG","PAY","LU0097036916.USD","CCOI","PLNT","SWTX","GTLB","RNA","AKYA","LU1496350171.SGD","CQP","BK4097","BK4099","MGX","PDCO","HIMS","DSP","BLD","FLT","LU0310799852.SGD","AMRC","SQSP","NTRA","LU1839511570.USD","NUVL","AMPH","HSIC","COST","IE0004445015.USD","LU1720051017.SGD","TSLA","SFIX","IBP","AKRO"],"gpt_icon":0},{"id":"2417176870","title":"美国研究综述-CommScope Holding Company、Dutch Bros、Hess","url":"https://stock-news.laohu8.com/highlight/detail?id=2417176870","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2417176870?lang=zh_cn&edition=full","pubTime":"2024-03-05 03:21","pubTimestamp":1709580103,"startTime":"0","endTime":"0","summary":"    路透社3月4日 - 华尔街证券分析师周一调整了对几家美国上市公司的评级和目标价，其中包括 CommScope Holding Company、Dutch Bros 和 Hess。要点 * CommScope Holding Company   ：摩根大通将其股票评级从中性下调至减持  * 荷兰兄弟  ：Piper Sandler 将其评级从中性上调至增持  * Hess Corp   ：Susquehanna 将目标价从 152 美元上调至 156 美元  * Pioneer Natural Resources Co   ：苏斯克汉纳将目标价从237美元上调至246美元  * United Therapeutics Corp   ：摩根大通将目标价从294美元下调至280美元  以下是路透社周一报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0979878070.USD","ACRE","APG","AAPL","AMPH","IE00B894F039.SGD","IE00BZ1G4Q59.USD","AHCO","LU1814569148.SGD","BXMT","BRP","RNAC","CHE","AHR","AKRO","AMRC","ARI","AVGO","BV","GTLS","BHVN","AVDX","BALL","LU0965509283.SGD","BK4110","COF","ANIP","AMD","BBIO","AZEK","APLS","BROS","BP","IE00BMPRXR70.SGD","CELH","BBWI","ANNX","BK4535","AI","APA","BLK","LU0234572021.USD","ABEV","ARIS","BK4129","BRFS","CHK","BRSP","AR","AEMD"],"gpt_icon":0},{"id":"2416901802","title":"Amphastar Pharmaceuticals, Inc.2023财年实现净利润1.38亿美元，同比增加51.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2416901802","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2416901802?lang=zh_cn&edition=full","pubTime":"2024-03-04 00:27","pubTimestamp":1709483241,"startTime":"0","endTime":"0","summary":"12月31日，Amphastar Pharmaceuticals, Inc.公布财报，公告显示公司2023财年净利润为1.38亿美元，同比增加51.00%；其中营业收入为6.44亿美元，同比增加29.06%，每股基本收益为2.85美元。从资产负债表来看，Amphastar Pharmaceuticals, Inc.总负债8.73亿美元，其中短期债务4.34百万美元，资产负债比为1.74，流动比率为2.18。机构评级：截至2023年12月31日，当前有4家机构对Amphastar Pharmaceuticals, Inc.目标价做出预测，其中目标均价为67.00美元，其中最低目标价为61.00美元，最高目标价为71.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030400272987e0e761&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030400272987e0e761&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMPH"],"gpt_icon":0},{"id":"2416529700","title":"Amphastar Pharmaceuticals, Inc.盘中异动 早盘股价大跌15.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2416529700","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2416529700?lang=zh_cn&edition=full","pubTime":"2024-02-29 22:32","pubTimestamp":1709217154,"startTime":"0","endTime":"0","summary":"北京时间2024年02月29日22时32分，Amphastar Pharmaceuticals, Inc.股票出现异动，股价大幅下挫15.34%。Amphastar Pharmaceuticals, Inc.股票所在的制药行业中，整体跌幅为0.62%。Amphastar Pharmaceuticals, Inc.公司简介：Amphastar Pharmaceuticals Inc 是一家生物制药公司，主要专注于开发、制造、营销和销售具有技术挑战性的仿制药和专有注射剂、吸入剂和鼻内产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022922323487d23f58&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022922323487d23f58&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4557","BK4007","AMPH","BK4585"],"gpt_icon":0},{"id":"2414319868","title":"Amphastar Pharmaceuticals Inc    预计每股收益 91 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2414319868","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2414319868?lang=zh_cn&edition=full","pubTime":"2024-02-27 05:33","pubTimestamp":1708983192,"startTime":"0","endTime":"0","summary":"   * Amphastar Pharmaceuticals Inc     将于2月28日公布截至2023年12月31日的财报，预计该公司的季度收入将有所增长。* 根据LSEG的数据，5位分析师的平均预期显示，这家总部位于加利福尼亚州Rancho Cucamonga的公司的营收有望从去年同期的1.3502亿美元增至1.7566亿美元，增幅为30.1%。   * LSEG 分析师对 Amphastar Pharmaceuticals Inc 的平均预期为每股收益 91 美分。* 华尔街对 Amphastar Pharmaceuticals Inc 的 12 个月目标价中位数为 68.00 美元，高于其上次收盘价 53.41 美元。2月26日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMPH"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.amphastar.com","stockEarnings":[{"period":"1week","weight":0.0235},{"period":"1month","weight":-0.011},{"period":"3month","weight":-0.01},{"period":"6month","weight":-0.2803},{"period":"1year","weight":-0.3738},{"period":"ytd","weight":-0.3596}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0009},{"period":"3month","weight":0.1087},{"period":"6month","weight":0.138},{"period":"1year","weight":0.2141},{"period":"ytd","weight":0.155}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Amphastar Pharmaceuticals, Inc.是一家加利福尼亚的公司，成立于1996年2月29日，于2004年7月和amphastar制药公司一家在特拉华成立的公司合并。公司是一家专业制药公司，主要开发，生产，销售市场上通用和专用注射和吸入产品，包括投资组合的市场进入壁垒高，通用和专利产品。大多数公司的产品用于住院或紧急护理的临床设置和主要承包通过集团采购组织和药品批发商。公司的产品主要分布在药企零售。","yearOnYearQuotes":[{"month":1,"riseRate":0.3,"avgChangeRate":-0.032241},{"month":2,"riseRate":0.4,"avgChangeRate":-0.000914},{"month":3,"riseRate":0.6,"avgChangeRate":0.041364},{"month":4,"riseRate":0.5,"avgChangeRate":0.008115},{"month":5,"riseRate":0.8,"avgChangeRate":0.069021},{"month":6,"riseRate":0.7,"avgChangeRate":0.072694},{"month":7,"riseRate":0.454545,"avgChangeRate":-0.006102},{"month":8,"riseRate":0.5,"avgChangeRate":0.008257},{"month":9,"riseRate":0.2,"avgChangeRate":-0.041791},{"month":10,"riseRate":0.4,"avgChangeRate":-0.013093},{"month":11,"riseRate":0.8,"avgChangeRate":0.089887},{"month":12,"riseRate":0.4,"avgChangeRate":0.020732}],"exchange":"NASDAQ","name":"Amphastar Pharmaceuticals","nameEN":"Amphastar Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Amphastar Pharmaceuticals(AMPH)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Amphastar Pharmaceuticals(AMPH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Amphastar Pharmaceuticals,AMPH,Amphastar Pharmaceuticals股票,Amphastar Pharmaceuticals股票老虎,Amphastar Pharmaceuticals股票老虎国际,Amphastar Pharmaceuticals行情,Amphastar Pharmaceuticals股票行情,Amphastar Pharmaceuticals股价,Amphastar Pharmaceuticals股市,Amphastar Pharmaceuticals股票价格,Amphastar Pharmaceuticals股票交易,Amphastar Pharmaceuticals股票购买,Amphastar Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Amphastar Pharmaceuticals(AMPH)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Amphastar Pharmaceuticals(AMPH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}